AZD 6244

Rous sarcoma oncogene ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34856074 Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. 2022 Mar 2
2 32876513 IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer. 2021 Mar 1